Last updated on December 2019

A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Migraine
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Participants with migraine with or without aura fulfilling the International Classification of Headache Disorders (ICHD)-2.
  • History of disabling migraine for at least 1 year.
  • Migraine Disability Assessment Test (MIDAS) score 11.
  • Migraine onset before the age of 50 years.
  • History of 3-8 migraine attacks per month and <15 headache days per month during the past 3 months.

Exclusion Criteria:

  • Known hypersensitivity to lasmiditan, or to any excipient of lasmiditan oral tablets.
  • History or evidence of hemorrhagic stroke, epilepsy, or any other condition placing the patient at increased risk of seizures.
  • History of recurrent dizziness and/or vertigo including benign paroxysmal positional vertigo, Meniere's disease, vestibular migraine, and other vestibular disorders.
  • History of diabetes mellitus with complications (diabetic retinopathy, nephropathy, or neuropathy).
  • History of orthostatic hypotension with syncope.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.